Vaccine development can be really expensive, and there’s limited commercial return.
- Calleva Head of Vaccine Immunology, University of Oxford
The Bundibugyo strain of Ebola causing the ongoing outbreak in the Democratic Republic of Congo currently has no vaccine. The Conversation Weekly podcast speaks to two researchers working to develop one.
Contact Teresa for
- General
- Media request
- Speaking request
- Consulting / Advising
- Research collaboration
- Research supervision
- Article Feed
- ORCID
- Joined

